Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Cyber Security

Salesforce Faces Dual Pressures: Insider Selling and FBI Cyberattack Warning

Dieter Jaworski by Dieter Jaworski
September 17, 2025
in Cyber Security, Insider Trading, Tech & Software
0
Salesforce Stock
0
SHARES
144
VIEWS
Share on FacebookShare on Twitter

The cloud computing behemoth Salesforce finds itself navigating turbulent waters as two significant developments converge. Chief Executive Marc Benioff continues his substantial divestment of company stock, while simultaneously, the Federal Bureau of Investigation has issued a stark warning regarding coordinated cyberattacks targeting the company’s platform infrastructure. These events are raising investor concerns about the stock’s near-term trajectory.

Federal Bureau of Investigation Sounds Alarm on Sophisticated Attacks

In a development with serious implications for Salesforce’s operational security, the FBI has alerted the public to targeted cyber campaigns directed at the company’s customer base. Multiple criminal collectives, identified by the Bureau as UNC6040 and UNC6395, are actively attempting to compromise client data for theft and extortion purposes.

The hacking groups are employing advanced and deceptive techniques to gain access. Their methods include voice phishing (vishing), where employees are manipulated over the phone into surrendering their login credentials. A second tactic involves exploiting compromised tokens from third-party applications that integrate with the Salesforce ecosystem. Most concerning is the confirmation that these attacks have already proven successful, with several businesses that rely on Salesforce having been breached.

CEO Marc Benioff Maintains Aggressive Stock Sale Schedule

Adding to the company’s challenges, co-founder and CEO Marc Benioff has been offloading shares at a significant pace. These sales, while executed under a pre-arranged trading plan, are drawing heightened scrutiny from the market given the current climate.

Should investors sell immediately? Or is it worth buying Salesforce?

His recent divestments include a disposal of 6,750 shares last week, realizing approximately $1.65 million. This follows a series of earlier transactions, including the sale of 2,250 shares for about $545,000 on September 15th. Prior to that, Benioff sold stock valued at nearly $549,000 on September 12th and another block worth $553,000 on September 11th. The consistent volume of these insider sales is being closely watched by concerned investors.

Dividend Payment Offers Little Solace Amidst Downturn

Amid these headwinds, the stock is trading ex-dividend. Shareholders of record are set to receive a quarterly distribution of $0.416 per share, which annualizes to a payout of $1.66. However, this dividend is unlikely to provide a meaningful counterbalance to the prevailing negative sentiment.

Salesforce shares continue to trade well below their key moving averages, struggling to break a persistent downward trend. With cybersecurity fears and executive stock sales dominating the narrative, the technical outlook for the stock remains under pressure.

Ad

Salesforce Stock: Buy or Sell?! New Salesforce Analysis from February 7 delivers the answer:

The latest Salesforce figures speak for themselves: Urgent action needed for Salesforce investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Salesforce: Buy or sell? Read more here...

Tags: Salesforce
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Quantum eMotion Stock
AI & Quantum Computing

Quantum eMotion Advances Toward US Exchange Listing

February 6, 2026
Next Post
Bloom Energy Stock

Bloom Energy Stock Reaches Record High on Analyst Optimism

TSMC Stock

TSMC Stock Reaches Unprecedented Peak Fueled by AI Expansion

Moderna Stock

Moderna Shares Rebound on Promising Vaccine Data

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com